Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191021045173N2Phase 2Completed
Phase 2, randomised, triple-blind trial in Helicobacter pylori infection and functional dyspepsia (FD) comparing Chlorhexidine oral gel with Sodium chloride oral gel (2 arms). Primary endpoint: Improvement in Global Overall Symptom scale score. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191021045173N2.